These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17394023)

  • 1. An introduction to biomarkers: applications to chronic kidney disease.
    Lemley KV
    Pediatr Nephrol; 2007 Nov; 22(11):1849-59. PubMed ID: 17394023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biomarkers in Chronic Kidney Disease].
    Munguía-Miranda C; Paniagua-Sierra JR
    Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S143-50. PubMed ID: 29697235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of early identification of chronic kidney disease.
    Whaley-Connell A; Nistala R; Chaudhary K
    Mo Med; 2011; 108(1):25-8. PubMed ID: 21462606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging biomarkers of chronic kidney disease in children.
    Greenberg JH; Kakajiwala A; Parikh CR; Furth S
    Pediatr Nephrol; 2018 Jun; 33(6):925-933. PubMed ID: 28624980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.
    Agarwal R; Duffin KL; Laska DA; Voelker JR; Breyer MD; Mitchell PG
    Nephrol Dial Transplant; 2014 Dec; 29(12):2293-302. PubMed ID: 25085239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for Assessing Longitudinal Biomarkers of Time-to-Event Outcomes in CKD: A Simulation Study.
    Liu Q; Smith AR; Mariani LH; Nair V; Zee J
    Clin J Am Soc Nephrol; 2019 Sep; 14(9):1315-1323. PubMed ID: 31416887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Kidney Disease.
    Webster AC; Nagler EV; Morton RL; Masson P
    Lancet; 2017 Mar; 389(10075):1238-1252. PubMed ID: 27887750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic biomarkers for chronic kidney disease.
    Ju W; Smith S; Kretzler M
    Transl Res; 2012 Apr; 159(4):290-302. PubMed ID: 22424432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic biomarkers for chronic kidney disease.
    Breit M; Weinberger KM
    Arch Biochem Biophys; 2016 Jan; 589():62-80. PubMed ID: 26235490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study.
    Aguiar P; Azevedo O; Pinto R; Marino J; Baker R; Cardoso C; Ducla Soares JL; Hughes D
    Mol Genet Metab; 2017 Jun; 121(2):162-169. PubMed ID: 28526293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for chronic kidney diseases among an adult population.
    Fatema K; Abedin Z; Mansur A; Rahman F; Khatun T; Sumi N; Kobura K; Akter S; Ali L
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):534-41. PubMed ID: 23640626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
    De Serres SA; Varghese JC; Levin A
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabonomic biomarkers for risk factors of chronic kidney disease.
    Ye L; Mao W
    Int Urol Nephrol; 2016 Apr; 48(4):547-52. PubMed ID: 26897037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.
    Pena MJ; de Zeeuw D; Mischak H; Jankowski J; Oberbauer R; Woloszczuk W; Benner J; Dallmann G; Mayer B; Mayer G; Rossing P; Lambers Heerspink HJ
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv86-95. PubMed ID: 26209743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.